No change
Add to watchlist
Create an alert
Stocks and Shares ISACizzle Biotechnology Holdings PLC is a United Kingdom-based diagnostics developer of early cancer tests. The Company is focused on early detection of lung cancer via the development of an immunoassay test for the CIZ1B biomarker. CIZ1B is a variant of CIZ1, a naturally occurring cell nuclear protein involved in protecting deoxyribonucleic acid (DNA). Its CIZ1B biomarker detects lung cancer at its earliest and most treatable stage. It is designed as a simple blood test, which enables early diagnosis before symptoms appear-when treatment options can transform outcomes for patients and families.
Company Information
About this company
Key people
Allan John Syms
Executive Chairman of the Board
Nigel Lee
Finance Director, Executive Director
Dawn Coverley
Chief Scientific Officer, Executive Director
Matt Bower
Non-Executive Director
Edwin Matthew
Non-Executive Director
John Treacy
Non-Executive Independent Director
Click to see more
Key facts
- Shares in issue396.39m
- EPICCIZ
- ISINGB00BNG2VN02
- LocationUnited Kingdom
- SectorHealthcare
- IndustryBiotechnology & Drugs
- Market cap£5.75m
- Employees67
- ExchangeLondon Stock Exchange (LON)
- Index
- Website
Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Overview data is sourced from Refinitiv.